A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Summary

The purpose of this study is to assess the cardiovascular safety of paliperidone in patients with schizophrenia or schizoaffective disorder, with particular attention to the length of the QT/QTc interval, to measure and review other electrocardiogram (ECG) parameters, such as QRS and PR intervals, to explore the relationship between the pharmacokinetics of paliperidone and ECG parameters of interest, and to explore the safety and tolerability of paliperidone

Timeline

Start

2005-02

Primary completion

—

Completion

2005-05

Drugs

Indications